Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Monday, November 23, 2009, 7:23PM AEST - The Australian Stockmarket is closed.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
PERSONAL FINANCE
SMALL BUSINESS
Enter symbol(s):
Symbol Lookup
|
Exchanges
Search News:
ROCHE HLDG LTD SPONS (RHHBY.PK)
On Nov 21:
40.10 USD
0.00 (0.00%)
MORE ON RHHBY.PK
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
Technical Analysis
Detailed Data
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
ROCHE HLDG LTD SPONS
(Other OTC:RHHBY.PK) Delayed quote data
Last Trade:
40.10 USD
Trade Time:
Nov 21
Change:
0.00 (0.00%)
Prev Close:
40.10
Open:
N/A
Bid:
N/A
Ask:
N/A
1y Target Est:
44.75
Day's Range:
N/A - N/A
52wk Range:
26.01 - 79.22
Volume:
0
Avg Vol
(3m)
:
379,023
Market Cap:
N/A
P/E
(ttm)
:
N/A
EPS
(ttm)
:
N/A
Div & Yield:
1.06 (2.65%)
1d
5d
3m
6m
1y
2y
5y
max
Add RHHBY.PK to Portfolio
Download Data
HEADLINES
Spectrum Pharma: Zevalin Sales Ramp Up
at Seeking Alpha
(Mon 12:32AM)
Desktop Bug Detector
at Forbes.com
(Sat, Nov 21)
Biotech Stocks: Senate bill weighs on Allergan, Medicis
at MarketWatch
(Fri, Nov 20)
454 Life Sciences Unveils New Bench Top Sequencer, Significant Improvements to the Genome Sequencer FLX System Including 1,000 bp Reads for 2010
Business Wire
(Fri, Nov 20)
New Cancer Research Tool: Roche's CIM-Plate 16 Enables Real-Time Analysis of Cell Migration on the xCELLigence System
Business Wire
(Thu, Nov 19)
Big Pullback for Top Swine Flu Small-Caps
Indie Research
(Wed, Nov 18)
Eurofins MWG Operon Joins Roche NimbleGen's Certified Service Provider Program for Targeted Enrichment and Sequencing Services
Business Wire
(Wed, Nov 18)
Roche unit files for 2 FDA clearances for Avastin
at MarketWatch
(Tue, Nov 17)
FDA Grants Emergency Use Authorization to Roche“s Assay for 2009 H1N1 Influenza Virus
Business Wire
(Tue, Nov 17)
Desktop Bug Detector
at Forbes.com
(Fri, Nov 13)
Researchers Use 454 Sequencing System to Complete Draft Genome Sequence for Cassava
Business Wire
(Wed, Nov 11)
More Headlines for RHHBY.PK...
ANALYST
EPS Est (next year)
(Dec-09)
:
2.88
EPS Est (in 2 years)
(Dec-10)
:
3.27
Avg Rec (current)*:
2.0
PEG Ratio:
1.37
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
No business summary available for RHHBY.PK.
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Australia
New Zealand
US
----------------
Argentina
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Malaysia
Mexico
Netherlands
Norway
Singapore
South Korea - Korea
South Korea - KOSDAQ
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Symbol Lookup
Latest News
7 Indices